CMS reviews NIV therapy for chronic respiratory failure

 - 
Wednesday, June 24, 2020

WASHINGTON – CMS on July 22 will conduct a virtual Medicare Evidence Development & Coverage Advisory Committee meeting to review the evidence specific to the home use of non-invasive ventilators by patients with chronic respiratory failure consequent to COPD. The agency seeks the committee’s recommendations on the characteristics that define patient selection and usage criteria, and concomitant services, as well as the equipment parameters necessary to best achieve positive patient health outcomes in beneficiaries with CRF consequent to COPD. MEDCAC doesn’t make coverage determinations, but CMS says it benefits from their advice.